Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis
For peripherally administered drugs to reach the central nervous system (CNS) and treat amyotrophic lateral sclerosis (ALS), they must cross the blood-brain barrier (BBB). As mounting evidence suggests that the ultrastructure of the BBB is altered in individuals with ALS and in animal models of ALS...
Saved in:
Main Authors: | Yijun Pan (Author), Yoshiteru Kagawa (Author), Jiaqi Sun (Author), Bradley J. Turner (Author), Cheng Huang (Author), Anup D. Shah (Author), Ralf B. Schittenhelm (Author), Joseph A. Nicolazzo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits
by: Saul Herranz-Martin, et al.
Published: (2017) -
Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations
by: Zsófia Flóra Nagy, et al.
Published: (2024) -
Inducible expression of human C9ORF72 36× G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice
by: Fréderike W. Riemslagh, et al.
Published: (2021) -
Dipeptide Repeat Pathology in <i>C9orf72</i>-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance
by: José Jiménez-Villegas, et al.
Published: (2022) -
Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity
by: Alan S. Premasiri, et al.
Published: (2020)